Gerald W. St. Peter
Fundador en Eyevance Pharmaceuticals LLC .
Perfil
Gerald W.
St. Peter is the founder.
He founded Eyevance Pharmaceuticals LLC in 2017, where he currently holds the title of Chief Executive Officer & Director.
In addition to his founding position, Mr. St. Peter has held former job positions.
He was the Chief Executive Officer & Director at Xequel Bio, Inc. and the President, Chief Executive Officer & Director at Eyevance Pharmaceuticals Holdings, Inc. He also served as the National Sales Director at MURO Pharmaceuticals, Inc. and as the Senior Vice President-Sales at Inspire Pharmaceuticals, Inc. from 2003 to 2010.
Furthermore, he held the position of Executive Vice President at Nicox SA. Mr. St. Peter's education history includes an undergraduate degree from the University of Massachusetts.
Cargos activos de Gerald W. St. Peter
| Empresas | Cargo | Inicio |
|---|---|---|
Eyevance Pharmaceuticals LLC
 Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals LLC operates as a pharmaceutical company. It develops and commercializes ophthalmic products that enable optimal vision for the patients. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Forth Worth, TX. | Fundador | 01/09/2017 |
Antiguos cargos conocidos de Gerald W. St. Peter.
| Empresas | Cargo | Fin |
|---|---|---|
Eyevance Pharmaceuticals Holdings, Inc.
 Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals Holdings, Inc operates as a holding company through its subsidiaries develops ophthalmic therapies for the ocular surface and anterior segment. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Fort Worth, TX. | Director Ejecutivo | - |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Director Ejecutivo | - |
MURO Pharmaceuticals, Inc.
 MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of RAG-Stiftung, MURO Pharmaceuticals, Inc. manufactures pharmaceuticals, specifically allergy and asthma products. The company is based in Tewksbury, MA. MURO Pharmaceuticals was acquired by ASTA Medica AG on September 30, 1996 for $120.70 million. | Ventas & Marketing | - |
| NICOX SA | Corporate Officer/Principal | - |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Corporate Officer/Principal | - |
Formación de Gerald W. St. Peter.
| University of Massachusetts | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NICOX SA | Health Technology |
| Empresas privadas | 5 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
MURO Pharmaceuticals, Inc.
MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of RAG-Stiftung, MURO Pharmaceuticals, Inc. manufactures pharmaceuticals, specifically allergy and asthma products. The company is based in Tewksbury, MA. MURO Pharmaceuticals was acquired by ASTA Medica AG on September 30, 1996 for $120.70 million. | Health Technology |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Health Technology |
Eyevance Pharmaceuticals LLC
Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals LLC operates as a pharmaceutical company. It develops and commercializes ophthalmic products that enable optimal vision for the patients. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Forth Worth, TX. | Health Technology |
Eyevance Pharmaceuticals Holdings, Inc.
Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals Holdings, Inc operates as a holding company through its subsidiaries develops ophthalmic therapies for the ocular surface and anterior segment. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Fort Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Gerald W. St. Peter